These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 3657877

  • 1. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B.
    N Engl J Med; 1987 Oct 29; 317(18):1101-4. PubMed ID: 3657877
    [Abstract] [Full Text] [Related]

  • 2. Efficacy trial of Vi polysaccharide vaccine against typhoid fever in south-western China.
    Yang HH, Wu CG, Xie GZ, Gu QW, Wang BR, Wang LY, Wang HF, Ding ZS, Yang Y, Tan WS, Wang WY, Wang XC, Qin M, Wang JH, Tang HA, Jiang XM, Li YH, Wang ML, Zhang SL, Li GL.
    Bull World Health Organ; 2001 Oct 29; 79(7):625-31. PubMed ID: 11477965
    [Abstract] [Full Text] [Related]

  • 3. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, Cadoz M, Armand J.
    Lancet; 1987 Nov 21; 2(8569):1165-9. PubMed ID: 2890805
    [Abstract] [Full Text] [Related]

  • 4. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, Manna B, Dutta S, Donner A, Kanungo S, Park JK, Puri MK, Kim DR, Dutta D, Bhaduri B, Acosta CJ, Clemens JD.
    N Engl J Med; 2009 Jul 23; 361(4):335-44. PubMed ID: 19625715
    [Abstract] [Full Text] [Related]

  • 5. [Efficacy and side effects following immunization with Salmonella typhi Vi capsular polysaccharide vaccine].
    Wang ZG, Zhou WZ, Shi J.
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Feb 23; 18(1):26-9. PubMed ID: 9812477
    [Abstract] [Full Text] [Related]

  • 6. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
    Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM.
    J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933
    [Abstract] [Full Text] [Related]

  • 7. [Conjugate vaccines against bacterial infections: typhoid fever].
    Paniagua J, García JA, López CR, González CR, Isibasi A, Kumate J.
    Salud Publica Mex; 1992 Aug 01; 34(3):268-73. PubMed ID: 1377407
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity of Vi capsular polysaccharide vaccine evaluated for three years in Korea.
    Kim YR, Yoo JH, Hur JK, Kang JH, Shin WS, Kang MW.
    J Korean Med Sci; 1995 Oct 01; 10(5):314-7. PubMed ID: 8750055
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan.
    Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, Nizami SQ, Acosta CJ, Clemens JD, Bhutta ZA, DOMI Typhoid Karachi Vi Effectiveness Study Group.
    Vaccine; 2012 Aug 03; 30(36):5389-95. PubMed ID: 22721899
    [Abstract] [Full Text] [Related]

  • 10. Experience with Salmonella typhi Vi capsular polysaccharide vaccine.
    Hessel L, Debois H, Fletcher M, Dumas R.
    Eur J Clin Microbiol Infect Dis; 1999 Sep 03; 18(9):609-20. PubMed ID: 10534182
    [Abstract] [Full Text] [Related]

  • 11. Revaccination with locally-produced vi typhoid polysaccharide vaccine among chinese school-aged children: safety and immunogenicity findings.
    Zhou WZ, Koo HW, Wang XY, Zhang J, Park JK, Zhu F, Deen J, Acosta CJ, Chen Y, Wang H, Galindo CM, Ochiai L, Park T, von Seidlein L, Xu ZY, Clemens JD.
    Pediatr Infect Dis J; 2007 Nov 03; 26(11):1001-5. PubMed ID: 17984806
    [Abstract] [Full Text] [Related]

  • 12. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO, Levine MM, Robbins JB.
    Vaccine; 1988 Aug 03; 6(4):307-8. PubMed ID: 3188615
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH, Hong JJ, Choi ES, Lee JW, Park JH.
    J Vet Sci; 2002 Jun 03; 3(2):67-70. PubMed ID: 12441674
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. IgA and IgG1 Specific to Vi Polysaccharide of Salmonella Typhi Correlate With Protection Status in a Typhoid Fever Controlled Human Infection Model.
    Dahora LC, Jin C, Spreng RL, Feely F, Mathura R, Seaton KE, Zhang L, Hill J, Jones E, Alam SM, Dennison SM, Pollard AJ, Tomaras GD.
    Front Immunol; 2019 Jun 03; 10():2582. PubMed ID: 31781100
    [Abstract] [Full Text] [Related]

  • 19. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD, Robbins JB.
    J Infect Dis; 1984 Sep 03; 150(3):436-49. PubMed ID: 6207249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.